"(《世界人权宣言》) ATLAS Drug Eluting Coronary Stent System is a next-generation cobalt-chromium (CoCr) stent platform coated with a sirolimus formulation (1 µg/mm²) designed to reduce restenosis in patients with coronary artery disease. By combining advanced laser-cutting technology and a clinically proven antiproliferative drug, the ATLAS system delivers durable vessel patency and a high safety profile in both de novo lesions and in-stent restenosis scenarios.
Cobalt-Chromium Alloy (L605) Construction
- Ensures exceptional strength-to-thickness ratio, enabling thinner struts without compromising radial force.
- Exhibits excellent corrosion resistance and biocompatibility for a stable healing environment.
Laser-Cut Stent Design
- Precision machining yields consistent strut geometry, promoting uniform drug distribution and an even healing surface along the vessel wall.
- Enhances stent deliverability, allowing smooth passage through calcified or tortuous coronary segments.
Sirolimus Elution Profile
- 1 µg/mm² of sirolimus is coated onto the stent’s surface, ensuring a sustained, controlled release that minimizes in-stent neointimal growth.
- Controlled drug release aids in rapid endothelialization, lowering the risk of late stent thrombosis.
Radiopaque Pt-Ir Markers
- Platinum-iridium markers at stent edges enable precise visibility under fluoroscopy.
- Facilitates accurate positioning during percutaneous coronary intervention (PCI) procedures.
High-Pressure Capability
interventional cardiologists flexibility to optimize stent expansion based on lesion complexity.
| 规格 | 细节/价值 |
| 产品名称 | Atlas Coronary Stent (Cobalt Chromium) |
| Stent Type | Balloon-Expandable Coronary Stent |
| 材料 | Cobalt-Chromium Alloy |
| Strut Thickness | ~80 µm (typical) |
| 设计 | Open-cell or hybrid-cell architecture (depending on exact model) |
| Nominal Pressure (NP) | 9–10 atm |
| Rated Burst Pressure (RBP) | ~14–16 atm |
| Stent Delivery System | Rapid-Exchange (RX) or Over-the-Wire (OTW), typically 140 cm shaft length |
| 导丝兼容性 | 0.014” |
| Stent Surface | Bare-metal or optional drug-eluting polymer (if applicable) |
| 适应症 | Coronary artery lesion scaffolding, single or multivessel disease, potential usage in small/medium/large vessels |
| 禁忌症 | Lesions unsuited for balloon-expandable stent therapy (e.g., severely calcified, left main trunk, etc.), or as per physician discretion |
| 无菌 | 无菌(环氧乙烷) |
| 一次性使用 | 是 |
| 保质期 | 2–3 years (depending on final packaging and polymer, if any) |
| 工作温度 | Recommended 15–25 °C for storage |
基于尺寸的详细订购和产品代码
| Stent Diameter (mm) | Stent Length (mm) | Nominal Pressure (atm) | RBP (atm) | 产品代码 |
| 2.00 | 8 | 9 | 14 | ATLS-CC-2.00x08 |
| 2.00 | 12 | 9 | 14 | ATLS-CC-2.00x12 |
| 2.00 | 15 | 9 | 14 | ATLS-CC-2.00x15 |
| 2.00 | 18 | 10 | 16 | ATLS-CC-2.00x18 |
| 2.00 | 24 | 10 | 16 | ATLS-CC-2.00x24 |
| 2.00 | 28 | 10 | 16 | ATLS-CC-2.00x28 |
| 2.00 | 32 | 10 | 16 | ATLS-CC-2.00x32 |
| 2.00 | 38 | 10 | 16 | ATLS-CC-2.00x38 |
| 2.25 | 8 | 9 | 14 | ATLS-CC-2.25x08 |
| 2.25 | 12 | 9 | 14 | ATLS-CC-2.25x12 |
| 2.25 | 15 | 9 | 14 | ATLS-CC-2.25x15 |
| 2.25 | 18 | 10 | 16 | ATLS-CC-2.25x18 |
| 2.25 | 24 | 10 | 16 | ATLS-CC-2.25x24 |
| 2.25 | 28 | 10 | 16 | ATLS-CC-2.25x28 |
| 2.25 | 32 | 10 | 16 | ATLS-CC-2.25x32 |
| 2.25 | 38 | 10 | 16 | ATLS-CC-2.25x38 |
| 2.50 | 8 | 9 | 14 | ATLS-CC-2.50x08 |
| 2.50 | 12 | 9 | 14 | ATLS-CC-2.50x12 |
| 2.50 | 15 | 9 | 14 | ATLS-CC-2.50x15 |
| 2.50 | 18 | 10 | 16 | ATLS-CC-2.50x18 |
| 2.50 | 24 | 10 | 16 | ATLS-CC-2.50x24 |
| 2.50 | 28 | 10 | 16 | ATLS-CC-2.50x28 |
| 2.50 | 32 | 10 | 16 | ATLS-CC-2.50x32 |
| 2.50 | 38 | 10 | 16 | ATLS-CC-2.50x38 |
| 2.75 | 8 | 9 | 14 | ATLS-CC-2.75x08 |
| 2.75 | 12 | 9 | 14 | ATLS-CC-2.75x12 |
| 2.75 | 15 | 9 | 14 | ATLS-CC-2.75x15 |
| 2.75 | 18 | 10 | 16 | ATLS-CC-2.75x18 |
| 2.75 | 24 | 10 | 16 | ATLS-CC-2.75x24 |
| 2.75 | 28 | 10 | 16 | ATLS-CC-2.75x28 |
| 2.75 | 32 | 10 | 16 | ATLS-CC-2.75x32 |
| 2.75 | 38 | 10 | 16 | ATLS-CC-2.75x38 |
| 3.00 | 8 | 9 | 14 | ATLS-CC-3.00x08 |
| 3.00 | 12 | 9 | 14 | ATLS-CC-3.00x12 |
| 3.00 | 15 | 9 | 14 | ATLS-CC-3.00x15 |
| 3.00 | 18 | 10 | 16 | ATLS-CC-3.00x18 |
| 3.00 | 24 | 10 | 16 | ATLS-CC-3.00x24 |
| 3.00 | 28 | 10 | 16 | ATLS-CC-3.00x28 |
| 3.00 | 32 | 10 | 16 | ATLS-CC-3.00x32 |
| 3.00 | 38 | 10 | 16 | ATLS-CC-3.00x38 |
| 3.25 | 12 | 9 | 14 | ATLS-CC-3.25x12 |
| 3.25 | 15 | 9 | 14 | ATLS-CC-3.25x15 |
| 3.25 | 18 | 10 | 16 | ATLS-CC-3.25x18 |
| 3.25 | 24 | 10 | 16 | ATLS-CC-3.25x24 |
| 3.25 | 28 | 10 | 16 | ATLS-CC-3.25x28 |
| 3.25 | 32 | 10 | 16 | ATLS-CC-3.25x32 |
| 3.25 | 38 | 10 | 16 | ATLS-CC-3.25x38 |
| 3.50 | 8 | 9 | 14 | ATLS-CC-3.50x08 |
| 3.50 | 12 | 9 | 14 | ATLS-CC-3.50x12 |
| 3.50 | 15 | 9 | 14 | ATLS-CC-3.50x15 |
| 3.50 | 18 | 10 | 16 | ATLS-CC-3.50x18 |
| 3.50 | 24 | 10 | 16 | ATLS-CC-3.50x24 |
| 3.50 | 28 | 10 | 16 | ATLS-CC-3.50x28 |
| 3.50 | 32 | 10 | 16 | ATLS-CC-3.50x32 |
| 3.50 | 38 | 10 | 16 | ATLS-CC-3.50x38 |
| 4.00 | 8 | 9 | 14 | ATLS-CC-4.00x08 |
| 4.00 | 12 | 9 | 14 | ATLS-CC-4.00x12 |
| 4.00 | 15 | 9 | 14 | ATLS-CC-4.00x15 |
| 4.00 | 18 | 10 | 16 | ATLS-CC-4.00x18 |
| 4.00 | 24 | 10 | 16 | ATLS-CC-4.00x24 |
| 4.00 | 28 | 10 | 16 | ATLS-CC-4.00x28 |
| 4.00 | 32 | 10 | 16 | ATLS-CC-4.00x32 |
| 4.00 | 38 | 10 | 16 | ATLS-CC-4.00x38 |
相关产品
-

Nexus 静脉和动脉套管
阅读更多多用途 静脉 和 动脉 辅助插管 体外循环 在心肺旁路或 ECMO 期间,确保最佳的 流速 和 血液相容性.
-

Extender 紫杉醇药物洗脱 PTCA 球囊导管
阅读更多A 紫杉醇涂层 冠状动脉球囊导管,旨在 减少再狭窄 在经皮冠状动脉腔内成形术(PTCA)期间,确保向血管壁有效输送药物。
-

Extender 药物洗脱 PTA 球囊导管
阅读更多Extender 药物洗脱 PTA 球囊导管;A 药物涂层 用于外周腔内血管成形术(PTA)的球囊,释放 抗增殖 减轻股动脉或腘动脉再狭窄的药物。
-

Stena 外围设备多层流量调节器
阅读更多分流 用于 外围 动脉,重新分配 层流 使血流从病变血管段流出,从而有助于动脉瘤或侧支的保留。
